Advertisement

Gastroenterologia Japonica

, Volume 28, Issue 1, pp 18–24 | Cite as

Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis

  • Shinichi Kakumu
  • Tadashi Shinagawa
  • Tetsuya Ishikawa
  • Kentaro Yoshioka
  • Takaji Wakita
  • Nobuo Ida
Liver, Pancreas and Biliary Tract
  • 30 Downloads

Summary

IL-6 production by peripheral blood mononuclear cells (PBMC) was studied in patients with chronic hepatitis B virus (HBV) infection and primary biliary cirrhosis (PBC) using the ELISA method. Spontaneous production of IL-6 was significantly increased in patients with HBeAg+ chronic hepatitis (CH). The cultures stimulated with lipopolysaccharide and lectin-free interleukin-2 (IL-2) showed enhanced IL-6 production both in controls and all patient groups compared with culture without any stimulation. IL-6 production in response to IL-2 was higher in patients with HBeAg+ CH and PBC than in controls. In PBMC with increased IL-6 production, monocyte function was increased in patients with HBeAg+ CH and PBC, while B cells from PBC showed elevated response to Staphylococcus aureus Cowan 1. IL-6 production in the presence of HBeAg was greater in anti-HBe+ patients than in HBeAg+ ones. These results suggest that IL-6 response is involved in the immune response in patients with chronic liver disease.

Key words

IL-6 production chronic hepatitis B PBC 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ferrari C, Penna A, DegliAntoni A, et al. Cellular immune response to hepatitis B virus antigens. An overview. J Hepatol 1988;7:21–33.PubMedCrossRefGoogle Scholar
  2. 2.
    Alexander GJM. Immunology of hepatitis B virus infection. Br Med Bull 1990;46:354–367.PubMedGoogle Scholar
  3. 3.
    Hoofnagle JH, Dusheiko GM, Seef LB, et al. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 1981;94:744–748.PubMedGoogle Scholar
  4. 4.
    James SP, Elson CO, Waggoner JG, et al. Deficiency of the autologous mixed lymphocyte reactions in patients with primary biliary cirrhosis. J Clin Invest 1980;66:1305–1310.PubMedGoogle Scholar
  5. 5.
    Hirano T, Yasukawa K, Harada H. Complementary DNA for a novel human interleukin (BSF-2) that induces B lympocytes to produce immunoglobulin. Nature 1986;324:73–76.PubMedCrossRefGoogle Scholar
  6. 6.
    Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990;8:253–278.PubMedCrossRefGoogle Scholar
  7. 7.
    Wolvekamp MCJ, Marquet RL. Interleukin-6: Historical background, genetics and biological significance. Immunol Lett 1990;24:l-10.CrossRefGoogle Scholar
  8. 8.
    Houssian FA, Devogelaer J-P, Van Damme J, et al. Interleukin 6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988;31: 784–788.CrossRefGoogle Scholar
  9. 9.
    Tanaka Y, Saito K, Shirakawa F, et al. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 1988;141:3043–3049.PubMedGoogle Scholar
  10. 10.
    Grubeck-Loebenstein B, Buchan G, Chantry D, et al. Analysis of intrathyroidal cytokine production in thyroid autoimmune disease: thyroid follicular cells produce interleukin-1 and interleukin6. Clin exp Immunol 1989;77:324–330.PubMedGoogle Scholar
  11. 11.
    Deviere J, Content J, Denys C, et al. High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin exp Immunol 1989;77:221–225.PubMedGoogle Scholar
  12. 12.
    Kakumu S, Shinagawa T, Ishikawa T, et al. Serum interlenkin 6 levels in patients with chronic hepatitis B. Am J Gastroenterol 1991;86:1495–1499.PubMedGoogle Scholar
  13. 13.
    Scheuer PJ. Primary biliary Cirrhosis. In: Liver Biopsy Interpretation, 3rd ed. London: Bailliere Tindall, 1980;36–59.Google Scholar
  14. 14.
    Kakumu S, Fuji A, Yoshioka K, et al. Pilot study of recombinant human interleukin 2 for chronic type B hepatitis. Hepatology 1988;8:487–492.PubMedCrossRefGoogle Scholar
  15. 15.
    Takahashi K, Fukuda A, Baba K, et al. Determination of e antigen and antibody to e by means of passive hemagglutination method. J Immunol 1977;119:1556–1559.PubMedGoogle Scholar
  16. 16.
    Tsutsumi Y, Kakumu S, Wakita, T, et al. In vitro production of antibody to hepatitis B core and e antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J Immunol 1990;144:2389–2393.PubMedGoogle Scholar
  17. 17.
    Ida N, Sakurai S, Hosaka T, et al. An enzyme-linked immunosorbent assay for the measurement of human interleukin-6. J Immunol Methods 1990;133:279–284.PubMedCrossRefGoogle Scholar
  18. 18.
    Ida N, Sakurai S, Hosaka T, et al. Establishment of strongly neutralizing monoclonal antibody to human interleukin-6 and its epitope analysis. Biochem Biophys Res Commun 1989;728–734.Google Scholar
  19. 19.
    Waage A, Kaufmann C, Espevik T, et al. Interleukin-6 in synovial fluid from patients with arthritis. Clin Immunol Immunopathol 1989;50:394–398.PubMedCrossRefGoogle Scholar
  20. 20.
    Nordan R, Potter M. A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 1986;233:566–569.PubMedCrossRefGoogle Scholar
  21. 21.
    Horii Y, Muraguchi A, Suematsu S, et al. Regulation of BSF-2/IL-6 production by human mononuclear cells. Macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 1988;141:1529–1535.PubMedGoogle Scholar
  22. 22.
    Jablons DM, Mule JJ, Mclntosh JK, et al. IL-6/IFN-Β-2 as a circulating hormone. Induction by cytokine administration in humans. J Immunol 1989;142:1542–1547.PubMedGoogle Scholar
  23. 23.
    Watson J, Mochizuki D. Interleukin 2: a class of T cell growth factors. Immunol Rev 1980; 51:257–278.PubMedCrossRefGoogle Scholar
  24. 24.
    Ming JE, Granelli-Piperno A. Distinctive features in the production of IL-6 by human T cells. Cell Immunol 1990;130:437–445.PubMedCrossRefGoogle Scholar
  25. 25.
    James SP, Jones EA, Hoofnagle JH, et al. Circulating activated B cells in primary biliary cirrhosis. J Clin Immunol 1985;5:254–260.PubMedCrossRefGoogle Scholar
  26. 26.
    Kakumu S, Yoshioka K, Tsutsumi Y, et al. Production of tumor necrosis factor, interleukin 1 and interferon-γ by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Clin Immunol Immunopathol 1990;56:54–65.PubMedCrossRefGoogle Scholar
  27. 27.
    Sehgal PB, Helfgott DC, Santhaanam U, et al. Regulation of the acute phase and immune responses in viral disease. Enhanced expression of the beta2-interferon/hepatocyte-stimulating factor/ interleukin 6 gene in virus-infected human fibroblasts. J Exp Med 1988;167:1951–1956.PubMedCrossRefGoogle Scholar
  28. 28.
    Frei K, Malipiero UV, Leist TP, et al. On the cellular source and function of interleukin 6 production in the central nervous system in viral disease. Eur J Immunol 1989; 19:689–694.PubMedCrossRefGoogle Scholar
  29. 29.
    Nakajima K, Martinez-Maza O, Hirano T, et al. Induction of IL-6 (B cell stimulatory factor-2/IFN-Β2) production by HIV. J Immunol 1989;142:531–536.PubMedGoogle Scholar

Copyright information

© The Japanese Society of Gastroenterology 1993

Authors and Affiliations

  • Shinichi Kakumu
    • 1
  • Tadashi Shinagawa
    • 1
  • Tetsuya Ishikawa
    • 1
  • Kentaro Yoshioka
    • 1
  • Takaji Wakita
    • 1
  • Nobuo Ida
    • 2
  1. 1.Third Department of Internal MedicineNagoya University School of MedicineNagoyaJapan
  2. 2.Basic Research LaboratoriesToray Industries, Inc.KamakuraJapan

Personalised recommendations